Both companies will jointly execute development and scale-up of multiple strategic APIs, including late-stage NCE-1 opportunities
The modular platform not only targets solid tumors but could also enhance traditional autologous and in vivo T cell therapies
Diversifying its portfolio to include late-phase antiviral agent
This remarkable increase from 17 in 2021 ranks among the fastest for pharmaceutical companies, establishing Lupin as a leader in sustainable growth
The successful refinancing and enhancement of the syndicated credit facilities provides access to an additional CHF 40 million
Moraine will serve as OTSAW’s exclusive distributor in Japan, deploying the Camello+ autonomous mobile robot and TransCar autonomous guided vehicle to support hospital logistics
Dragon Copilot integrates generative AI, ambient listening, and natural language processing (NLP) to capture and document care directly
The pharma giant's 11% rise in total revenue to $43.2 billion highlights consistent execution of its growth strategy
Organic capex during the quarter amounted to Rs. 491.1 crore, supporting ongoing business expansion initiatives
Venus Remedies now has 29 active product approvals in Vietnam alone
Subscribe To Our Newsletter & Stay Updated
